HBW Advisory Services LLC Sells 4,490 Shares of iShares Biotechnology ETF $IBB

HBW Advisory Services LLC decreased its stake in iShares Biotechnology ETF (NASDAQ:IBB) by 73.8% in the 1st quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 1,594 shares of the financial services provider’s stock after selling 4,490 shares during the period. HBW Advisory Services LLC’s holdings in iShares Biotechnology ETF were worth $269,000 as of its most recent filing with the Securities and Exchange Commission.

Other hedge funds also recently made changes to their positions in the company. Citigroup Inc. boosted its holdings in iShares Biotechnology ETF by 40.9% in the fourth quarter. Citigroup Inc. now owns 5,242,688 shares of the financial services provider’s stock valued at $884,808,000 after acquiring an additional 1,521,992 shares during the last quarter. Raymond James Financial Inc. increased its position in iShares Biotechnology ETF by 286.2% during the 4th quarter. Raymond James Financial Inc. now owns 994,311 shares of the financial services provider’s stock valued at $167,810,000 after purchasing an additional 736,881 shares during the period. WestEnd Advisors LLC acquired a new stake in iShares Biotechnology ETF during the 4th quarter valued at approximately $106,276,000. Truist Financial Corp raised its holdings in iShares Biotechnology ETF by 2,239.6% during the 4th quarter. Truist Financial Corp now owns 642,023 shares of the financial services provider’s stock worth $108,354,000 after purchasing an additional 614,582 shares during the last quarter. Finally, LPL Financial LLC raised its holdings in iShares Biotechnology ETF by 145.9% during the 4th quarter. LPL Financial LLC now owns 992,799 shares of the financial services provider’s stock worth $167,555,000 after purchasing an additional 589,033 shares during the last quarter. 62.45% of the stock is currently owned by institutional investors.

iShares Biotechnology ETF Stock Performance

Shares of NASDAQ IBB opened at $189.90 on Thursday. The company’s 50 day moving average price is $177.00 and its 200-day moving average price is $173.16. iShares Biotechnology ETF has a 52-week low of $128.84 and a 52-week high of $199.05.

iShares Biotechnology ETF Cuts Dividend

The company also recently announced a quarterly dividend, which was paid on Thursday, June 18th. Investors of record on Monday, June 15th were paid a dividend of $0.0238 per share. This represents a $0.10 dividend on an annualized basis and a yield of 0.1%. The ex-dividend date of this dividend was Monday, June 15th.

iShares Biotechnology ETF Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.